Advertisement

Uterine Cancer pp 445-459 | Cite as

Palliative Care and End of Life Options for Patients with Endometrial Cancer

  • Angelique Wong
  • Suresh Reddy

Abstract

Palliative care is an approach that improves the quality of life of patients and their families facing life-threatening illness, through the prevention and relief of suffering by means of early identification assessment and treatment of pain and other problems, such as physical, psychosocial, and spiritual [1]. Palliative care is a complex specialty that emphasizes the need to provide early, effective symptom management to patients with serious illnesses and can be implemented and integrated at any point in the disease trajectory, not just at the end of life.

Keywords

Palliative Care Neuropathic Pain Endometrial Cancer National Comprehensive Cancer Network Music Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    WHO: Pain Relief and Palliative Care. National cancer control programmes: policies and managerial guidelines. 2nd ed. Geneva; 2002. p. 83–91.Google Scholar
  2. 2.
    Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999;353:1695–700.CrossRefPubMedGoogle Scholar
  3. 3.
    Fisch MJ, Lee JW, Weiss M, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012;30(16):1980–8.Google Scholar
  4. 4.
    Dalal S, Del Fabbro E, Bruera E. Symptom control in palliative care—part I: oncology as a paradigmatic example. J Palliat Med. 2006;9(2):391–408.CrossRefPubMedGoogle Scholar
  5. 5.
    Merskey H, Bogduk N. Pain terms, a current list with definitions and notes on usage. In: Merskey H, Bogduk N, editors. Classification of chronic pain, IASP task force on taxonomy. 2nd ed. Seattle: IASP Press; 1994. p. 209–14.Google Scholar
  6. 6.
    Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The edmonton symptom assessment system: a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.PubMedGoogle Scholar
  7. 7.
    Cancer pain relief and palliative care. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1990;804:1–75.Google Scholar
  8. 8.
    Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174(11):1589–94.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Reddy S, Fisch M, Bruera E. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes. J Pain Symptom Manage. 2004;28(4):301–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, et al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010;13(1):33–8.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Giller CA. The neurosurgical treatment of pain. Arch Neurol. 2003;60(11):1537–40.CrossRefPubMedGoogle Scholar
  12. 12.
    Gutgsell KJ, Schluchter M, Margevicius S, et al. Music therapy reduces pain in palliative care patients: a randomized controlled trial. J Pain Symptom Manage. 2013;45(5):822–31.CrossRefPubMedGoogle Scholar
  13. 13.
    Archie P, Bruera E, Cohen L. Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature. Support Care Cancer. 2013;21(9):2609–24.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Astin JA. Mind-body therapies for the management of pain. Clin J Pain. 2004;20(1):27–32.CrossRefPubMedGoogle Scholar
  15. 15.
    Peuckmann-Post V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010;10(11), CD006788.Google Scholar
  16. 16.
    Mercadante S, Porzio G. Octreotide for malignant bowel obstruction: twenty years after. Crit Rev Oncol Hematol. 2012;83(3):388.CrossRefPubMedGoogle Scholar
  17. 17.
    Ang SK, Shoemaker LK, Davis MP. Nausea and vomiting in advanced cancer. Am J Hosp Palliat Care. 2010;27(3):219–25.CrossRefPubMedGoogle Scholar
  18. 18.
    Tarumi Y, Wilson MP, Szafran O, Spooner GR. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage. 2013;45(1):2.CrossRefPubMedGoogle Scholar
  19. 19.
    Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med. 2008;11(4):575–81.CrossRefPubMedGoogle Scholar
  20. 20.
    Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted nutrition for palliative care in adult patients. Cochrane Database Syst Rev. 2008;4:CD006274.PubMedGoogle Scholar
  21. 21.
    Akechi T, Okuyama T, Onishi J, Morita T, Furukawa TA. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev. 2008;2:CD005537.PubMedGoogle Scholar
  22. 22.
    Fernandez F, Adams F, Holmes VF, Levy JK, Neidhart M. Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants. Psychosomatics. 1987;28:455–61.CrossRefPubMedGoogle Scholar
  23. 23.
    Olin J, Masand P. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics. 1996;37:57–62.CrossRefPubMedGoogle Scholar
  24. 24.
    Macleod AD. Methylphenidate in terminal depression. J Pain Symptom Manage. 1998;16:193–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Homsi J, Nelson KA, Sarhill N, et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care. 2001;18:403–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Kerr CW, Drake J, Milch RA, et al. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 2012;43:68–77.CrossRefPubMedGoogle Scholar
  27. 27.
    Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997;79(4):835.CrossRefPubMedGoogle Scholar
  28. 28.
    Bruera E, Bush SH, Willey J, Paraskevopoulos T, Li Z, Palmer JL, Cohen MZ, Sivesind D, Elsayem A. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer. 2009;115(9):2004.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153(2):231.CrossRefPubMedGoogle Scholar
  30. 30.
    Clemens KE, Faust M, Bruera E. Update on combined modalities for the management of breathlessness. Curr Opin Support Palliat Care. 2012;6(2):163–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Philip J, Gold M, Milner A, et al. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2006;32:541–50.CrossRefPubMedGoogle Scholar
  32. 32.
    Hugel H, Ellershaw JE, Cook L, Skinner J, Irvine C. The prevalence, key causes and management of insomnia in palliative care patients. J Pain Symptom Manage. 2004;27(4):316.CrossRefPubMedGoogle Scholar
  33. 33.
    Beck M, Wanchai A, Stewart BR, Cormier JN, Armer JM. Palliative care for cancer-related lymphedema: a systematic review. J Palliat Med. 2012;15(7):821.CrossRefPubMedGoogle Scholar
  34. 34.
    Uccella S, Morris JM, Bakkum-Gamez JN, Keeney GL, Podratz KC, Mariani A. Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature. Gynecol Oncol. 2013;130(3):474–82.PubMedCentralCrossRefPubMedGoogle Scholar
  35. 35.
    Janjan N, Lutz ST, Bedwinek JM, Hartsell WF, Ng A, Pieters Jr RS, Ratanatharathorn V, Silberstein EB, Taub RJ, Yasko AW, Rettenmaier A, American College of Radiology. Therapeutic guidelines for the treatment of bone metastasis: a report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. J Palliat Med. 2009;12(5):417–26.CrossRefPubMedGoogle Scholar
  36. 36.
    Gralow J, Tripathy D. Managing metastatic bone pain: the role of bisphosphonates. J Pain Symptom Manage. 2007;33(4):462–72.CrossRefPubMedGoogle Scholar
  37. 37.
    Hui D, dos Santos R, Chisholm G, Bansal S, Silva TB, Kilgore K, Crovador CS, Yu X, Swartz MD, Perez-Cruz PE, Leite Rde A, Nascimento MS, Reddy S, Seriaco F, Yennu S, Paiva CE, Dev R, Hall S, Fajardo J, Bruera E. Clinical signs of impending death in cancer patients. Oncologist. 2014;19(6):681.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Palliative CareThe University of Texas, MD Anderson Cancer CenterHoustonUSA

Personalised recommendations